Defy Medical AI Market Strategy Report - TRT Clinics

Answer Capsule

Defy Medical is the second-strongest brand in the TRT Clinics category by valid recommendation coverage, holding 40.83% in September 2026, just 1.83 points behind category leader Hone Health at 42.66%. The brand is visible and well-framed, with a net sentiment score of 0.9135, the highest in the tracked set, and it converts 47.71% raw mention presence into 89 valid recommendations across 218 qualified observations. Its clearest weakness is a two-month decline in coverage, down 8.0 points from 48.8% in July 2026, alongside a narrowing top-three rate of 19.72% and a rank-one rate of just 3.67%. The clearest opportunity sits in the consideration cluster, where Defy Medical already holds strong placement but still trails Hone Health on top-three and rank-one frequency.

Who This Report Is For

This report is for TRT clinic operators, digital strategy leads, and category marketers who need to understand how AI systems are recommending testosterone therapy providers and where Defy Medical stands in that recommendation layer.

Report Card

Executive Summary

Defy Medical holds the second position in the TRT Clinics AI recommendation landscape for September 2026, with 40.83% valid recommendation coverage across 218 qualified observations. The brand trails Hone Health by 1.83 points, a margin narrow enough that the leadership position is contestable month to month. Defy Medical also carries the strongest net sentiment score in the tracked set at 0.9135, meaning that when AI systems mention the brand, the framing is overwhelmingly positive.

The brand's raw mention presence rate sits at 47.71%, meaning Defy Medical appears in nearly half of all qualified AI responses. Of those appearances, 89 converted into valid recommendations, the second-highest count in the category behind Hone Health's 93. The conversion from presence to recommendation is strong relative to most competitors, but the brand is not converting that presence into first-position recommendations at the same rate as its closest rival.

The strongest cluster for Defy Medical is the consideration-stage cluster, Best TRT Clinics and Top Testosterone Therapy Providers, which is also the only cluster with qualified observations in the September 2026 benchmark. Within that cluster, Defy Medical holds a top-three rate of 19.72% and a rank-one rate of 3.67%. Hone Health holds a top-three rate of 33.94% and a rank-one rate of 8.26% in the same cluster, meaning the category leader appears in the top three roughly 14 points more often and as the first recommendation more than twice as often.

The clearest gap for Defy Medical is not presence or sentiment but placement prominence. The brand is mentioned frequently and framed positively, yet it is recommended as the first option in only 8 of 218 qualified observations. Maximus, which holds lower overall coverage at 27.52%, achieves a higher rank-one rate at 9.63%, suggesting that Defy Medical's recommendation strength is broad but not concentrated at the top of the shortlist.

The strongest platform signal for Defy Medical comes from Google AI Overviews, where the brand holds a 30.85% valid recommendation coverage rate and a 15.96% top-three rate across 94 platform observations. The weakest platform signal is Perplexity, where Defy Medical holds a 33.33% valid recommendation coverage rate but no rank-one placements across 6 observations, and Gemini, where the brand holds a 60.00% valid recommendation coverage rate but no rank-one placements across 20 observations.

Month over month, Defy Medical declined from 48.8% coverage in July 2026 to 40.8% in September 2026, a cumulative 8.0-point drop. The decline did not register as a statistically significant movement against the July baseline, but it has now run for two consecutive months and has narrowed the gap to Hone Health only because both brands fell. The brand's top-three rate also slipped from 23.9% in July to 19.7% in September, and its rank-one rate moved from 4.3% to 3.7%.

What Defy Medical Is Winning

Questions This Section Answers

• Where does Defy Medical's net sentiment advantage over competitors come from?
• Which platforms and clusters show the strongest recommendation signal for Defy Medical?

Defy Medical holds the highest net sentiment score in the TRT Clinics category at 0.9135, meaning that AI systems frame the brand positively in the overwhelming majority of mentions. This is a meaningful asset because positive framing supports recommendation conversion and reduces the risk of cautionary or comparison-anchor placements.

The brand also holds the second-highest valid recommendation count at 89, behind only Hone Health at 93. With 104 total mentions across 218 qualified observations, Defy Medical converts 85.6% of its mentions into valid recommendations, a conversion rate that exceeds Hone Health's 55.4% and Maximus's 75.0%. This suggests that when AI systems mention Defy Medical, they are highly likely to recommend it rather than simply reference it.

Defy Medical's strongest platform by recommendation coverage is Gemini, where it holds a 60.00% valid recommendation coverage rate across 20 platform observations. The brand also performs well on Google AI Overviews, holding a 30.85% valid recommendation coverage rate and a 15.96% top-three rate across 94 observations. These two platforms represent the clearest pockets of recommendation strength for the brand.

The brand's strongest cluster is the consideration-stage cluster, Best TRT Clinics and Top Testosterone Therapy Providers, where it holds a 19.72% top-three rate and a 3.67% rank-one rate. This cluster captures buyers who are actively identifying and evaluating TRT clinic options, making it the most commercially relevant cluster in the current benchmark.

Where Defy Medical Has the Clearest AI Visibility Gaps

Questions This Section Answers

• Why does Defy Medical rank first so rarely despite frequent recommendations?
• Which platforms show recommendation presence without top-position conversion?

Defy Medical's clearest gap is recommendation placement at the top of the shortlist. The brand holds a 19.72% top-three rate and a 3.67% rank-one rate, while Hone Health holds a 33.94% top-three rate and an 8.26% rank-one rate. Maximus, which holds lower overall coverage, achieves a 9.63% rank-one rate, more than double Defy Medical's first-position frequency. This means that Defy Medical is frequently recommended but rarely recommended first.

The brand also shows a gap on Perplexity, where it holds a 33.33% valid recommendation coverage rate across 6 observations but no rank-one placements. On Gemini, Defy Medical holds a 60.00% valid recommendation coverage rate but again no rank-one placements across 20 observations. These platforms represent opportunities to convert existing recommendation presence into first-position recommendations.

Defy Medical's presence rate declined from 53.6% in July 2026 to 47.71% in September 2026, a 5.9-point drop. The brand's top-three rate also declined from 23.9% to 19.72%, and its rank-one rate moved from 4.3% to 3.67%. These declines suggest that the brand is losing ground across multiple placement tiers, not just at the top of the shortlist.

The brand's valid recommendation count fell from 102 in July 2026 to 89 in September 2026, a loss of 13 recommendations. This decline is broad-based rather than concentrated in a single placement tier, suggesting a shift in which prompts surface the brand rather than a change in how prominently it ranks within those prompts.

Biggest Opportunity

Questions This Section Answers

• What would it take for Defy Medical to close the rank-one gap with Hone Health?
• Where should Defy Medical focus to convert its presence into first-position recommendations?

Defy Medical's biggest opportunity is converting its existing recommendation presence into first-position recommendations. The brand already holds the second-highest valid recommendation count and the highest net sentiment score in the category, but it ranks first in only 8 of 218 qualified observations. Closing the rank-one gap with Hone Health, which holds 18 first-position recommendations, would require targeted work on the prompt and citation layers that determine which brand AI systems place at the top of the shortlist.

This opportunity is concentrated in the consideration-stage cluster, where buyers are actively identifying and evaluating TRT clinic options. Defy Medical already holds strong presence and positive framing in this cluster, but it trails Hone Health on both top-three and rank-one frequency. The path from reference to recommendation to first-position recommendation runs through the owned answer layer, the citation architecture, and the public evidence layer that AI systems retrieve and synthesize when forming recommendations.

Competitive Landscape

Questions This Section Answers

• How does Defy Medical's placement profile compare with Hone Health and Maximus?
• Which competitors are strongest on rank-one and average recommended rank?

Hone Health and Defy Medical hold the strongest recommendation-stage positions in the TRT Clinics category, with Hone Health leading on coverage and Defy Medical leading on sentiment. Maximus holds the highest rank-one rate among the top tier, while Marek Health and Henry Meds occupy the middle of the field. The table below shows the full tracked set sorted by top-three rate.

Average recommended rank covers rank-eligible recommendations only.

Defy Medical ranks third by top-three rate, behind Hone Health and Maximus, despite holding the second-highest valid recommendation coverage. The brand's average recommended rank of 3.24 is higher (worse) than Hone Health's 2.21 and Maximus's 2.13, indicating that when Defy Medical is recommended, it typically appears later in the shortlist. The brand's rank-one rate of 3.67% is less than half of Maximus's 9.63% and less than half of Hone Health's 8.26%.

Prompt Evidence

Google AI Overviews / Best TRT Clinics and Top Testosterone Therapy Providers Prompt: "best testosterone replacement therapy" Result: Defy Medical appeared in the response and received a valid recommendation, contributing to its 30.85% coverage rate on this platform.

ChatGPT / Best TRT Clinics and Top Testosterone Therapy Providers Prompt: "online doctors that prescribe testosterone" Result: Defy Medical received a valid recommendation with a rank-one placement, one of only 3 rank-one placements the brand achieved on ChatGPT across 12 platform observations.

Gemini / Best TRT Clinics and Top Testosterone Therapy Providers Prompt: "trt clinic" Result: Defy Medical appeared in the response and received a valid recommendation, but no rank-one placement, consistent with the brand's pattern of presence without first-position conversion on Gemini.

Perplexity / Best TRT Clinics and Top Testosterone Therapy Providers Prompt: "online testosterone therapy" Result: Defy Medical received a valid recommendation but no rank-one placement across 6 platform observations, reflecting the brand's broader pattern of recommendation presence without top-position conversion on Perplexity.

What CiteWorks Studio Would Do Next

Phase 1: AI Market Discovery Audit Map the specific prompts where Defy Medical is mentioned but not recommended first, and identify which competitors capture the rank-one position in those prompts.

Phase 2: Recommendation Readiness Plan Prioritize the consideration-stage cluster and the platforms where Defy Medical holds recommendation presence but no rank-one placements, particularly Gemini and Perplexity.

Phase 3: Owned Answer Layer Buildout Strengthen the brand's owned pages and structured content so that AI systems have clear, retrievable evidence that supports first-position recommendation.

Phase 4: Citation and Authority Layer Development Build the public evidence layer, including third-party sources, comparison pages, and authority signals, that AI systems retrieve when forming TRT clinic recommendations.

Phase 5: Monthly AI Visibility and Recommendation Tracking Track Defy Medical's top-three rate, rank-one rate, and average recommended rank month over month to measure whether the brand is closing the placement gap with Hone Health and Maximus.

Why This Matters

Questions This Section Answers

• What does Defy Medical's rank-one frequency tell us about its position in the AI-generated shortlist?
• How do Hone Health and Maximus compare to Defy Medical on first-position recommendations?

AI systems are now forming the buyer shortlist for TRT clinic services. When a prospective patient asks an AI assistant for the best testosterone replacement therapy provider, the answer that comes back is not a list of every clinic in the category. It is a shortlist, often ranked, and the brands that appear at the top of that shortlist capture the recommendation moment.

Defy Medical is visible, positively framed, and frequently recommended. But visibility alone is not enough. The brand ranks first in only 8 of 218 qualified observations, while Hone Health ranks first in 18 and Maximus ranks first in 21. Closing that gap requires targeted correction of the prompt, page, and citation layers that determine which brand AI systems place at the top of the shortlist.

Core Metrics

Sentiment Score

Questions This Section Answers

• How is Defy Medical's sentiment score calculated and what does it indicate?
• Why is classified sentiment more useful than overall mention count?

Sentiment Score = (positive mentions × 1 + neutral mentions × 0 + negative mentions × -1) / total mentions

Defy Medical's sentiment score for September 2026 is 0.9135, calculated from 95 positive mentions, 9 neutral mentions, and 0 negative mentions across 104 total mentions. This is the highest sentiment score in the TRT Clinics category, ahead of Maximus at 0.8750 and Marek Health at 0.8163.

Sentiment score matters because unclassified mention counts are misleading. A brand that appears frequently but is framed negatively or neutrally is not in the same position as a brand that appears frequently and is framed positively. Share of voice is a diagnostic metric, not a business KPI. A positive recommendation, a neutral reference, a cautionary mention, and a competitor-displaced mention are not equal in commercial value.

Counting all mentions as wins is bad measurement. Defy Medical's 104 mentions include 9 neutral references that do not carry recommendation weight. The brand's 89 valid recommendations are the commercially meaningful signal, and its 0.9135 sentiment score indicates that the framing of those recommendations is overwhelmingly positive. Classified sentiment is required before interpreting AI visibility because it separates recommendation strength from mere presence.

Sentiment by Platform

Questions This Section Answers

• Which platforms show the strongest sentiment for Defy Medical?
• Where is sentiment high but the sample size too small for a strong conclusion?

Methodology

1. Report orientation: This is a benchmark-based AI Company Market Strategy Report for Defy Medical in the TRT Clinics category, derived from the LLM Authority Index AI Market Discovery Index for September 2026.
2. Reporting window: The September 2026 measurement covers the period ending September 1, 2026, with comparisons to the July 2026 baseline and the August 2026 intermediate measurement.
3. Platforms tracked: Six canonical AI and search surface families were tracked: ChatGPT, Copilot, Gemini, Perplexity, Google AI Overviews, and Google AI Mode.
4. Observation count: The September 2026 benchmark began with 800 prompt-surface observations, produced 535 unique questions after deduplication, retained 428 relevant observations, and qualified 218 observations for public analysis.
5. Competitor universe: Ten brands were tracked: BioTE, Craft Concierge, Defy Medical, Fountain TRT, Henry Meds, Hone Health, Low T Center, Marek Health, Maximus, and Renew Vitality.
6. Public clusters used: All 218 qualified observations in September 2026 fell into the Brand Recommendation buyer-intent class, corresponding to the consideration-stage cluster Best TRT Clinics and Top Testosterone Therapy Providers. No qualified observations landed in the Pricing and Value or Multi-Brand Comparison classes.
7. Stage 0 role: Stage 0 extraction retained the query, AI surface, answer, brand outcome, recommendation placement, sentiment, and, where exposed, citations or attributable evidence sources for each observation.
8. Definition of a mention: A mention is any qualified observation in which Defy Medical appears in the AI response, regardless of whether the brand is recommended.
9. Definition of a valid recommendation: A valid recommendation is a qualified observation in which Defy Medical receives a clear, actionable recommendation. Neutral references, cautionary mentions, and comparison-anchor placements are not counted as valid recommendations unless the dataset explicitly marks them as such.
10. Ranking interpretation: Top-three rate measures how often Defy Medical appears among the first three recommendations. Rank-one rate measures how often the brand is the first recommendation. Average recommended rank covers rank-eligible recommendations only.
11. Limitations: The public benchmark does not measure market share, attributable sales, every possible AI response, organic-search ranking, social mention volume, or private or sponsored channels. A metric movement alone does not establish causality. The current public series measures Brand Recommendation discovery only and does not yet contain qualified observations in the Pricing and Value or Multi-Brand Comparison classes.
12. Small-count note: Low T Center, Craft Concierge, BioTE, and Renew Vitality operate on 5 or fewer valid recommendations; a change of one or two answers moves their percentages materially. Defy Medical's 89 valid recommendations provide a stable base for month-over-month comparison.

See Where AI Is Recommending Your Brand

The public benchmark shows where Defy Medical stands in the TRT Clinics category. A company-level AI visibility audit maps the specific prompts, platforms, and citation sources that determine whether Defy Medical is recommended first, recommended later in the shortlist, or not recommended at all. The audit isolates the queries where the brand's position is eroding, identifies the competitor capturing those recommendations, and pinpoints the evidence gaps that need attention.